메뉴 건너뛰기




Volumn 83, Issue 6, 2008, Pages 505-507

Lysis and thrombosis: Manifestation of the same disease

Author keywords

[No Author keywords available]

Indexed keywords

COLD AGGLUTININ; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; HOMOCYSTEINE; METHYLMALONIC ACID;

EID: 44349127769     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21141     Document Type: Article
Times cited : (6)

References (10)
  • 1
    • 0000579387 scopus 로고
    • Paroxysmal nocturnal hemoglobinuria: A classic description by Paul Strübing in 1882, and a bibliography of the disease
    • Crosby WH. Paroxysmal nocturnal hemoglobinuria: a classic description by Paul Strübing in 1882, and a bibliography of the disease. Blood 1951;6:270-284.
    • (1951) Blood , vol.6 , pp. 270-284
    • Crosby, W.H.1
  • 2
    • 44349163191 scopus 로고    scopus 로고
    • New insights into paroxysmal nocturnal hemoglobinuria
    • Epub ahead of print
    • Savage WJ, Brodskey RA. New insights into paroxysmal nocturnal hemoglobinuria. Hematology 2007;20:1 (Epub ahead of print).
    • (2007) Hematology , vol.20 , pp. 1
    • Savage, W.J.1    Brodskey, R.A.2
  • 3
    • 28444483571 scopus 로고    scopus 로고
    • Diagnosis and management of paroxysmal nocturnal hemoglobinuria
    • Parker C, Omine M, Richards S. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005;12:106-112.
    • (2005) Blood , vol.12 , pp. 106-112
    • Parker, C.1    Omine, M.2    Richards, S.3
  • 4
    • 33748904355 scopus 로고    scopus 로고
    • The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
    • Hillmen P, Young NS, Schubert J. The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. N Eng J Med 2006;355:1233-1243.
    • (2006) N Eng J Med , vol.355 , pp. 1233-1243
    • Hillmen, P.1    Young, N.S.2    Schubert, J.3
  • 5
    • 10744228553 scopus 로고    scopus 로고
    • Effect of Eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria
    • Hillmen P, Hall C, Marsh JC. Effect of Eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Eng J Med. 2004;350:552-559.
    • (2004) N Eng J Med , vol.350 , pp. 552-559
    • Hillmen, P.1    Hall, C.2    Marsh, J.C.3
  • 6
    • 35948962168 scopus 로고    scopus 로고
    • Effect of complement inhibitor Eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
    • Hillmen P, Muus P, Dührsen U. Effect of complement inhibitor Eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 2007;110:4123-4128.
    • (2007) Blood , vol.110 , pp. 4123-4128
    • Hillmen, P.1    Muus, P.2    Dührsen, U.3
  • 7
    • 44349157383 scopus 로고    scopus 로고
    • Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH)
    • Hall C, Richards S, Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood 2003;11:102-110.
    • (2003) Blood , vol.11 , pp. 102-110
    • Hall, C.1    Richards, S.2    Hillmen, P.3
  • 8
    • 28144438019 scopus 로고    scopus 로고
    • Cerebral Ischemic Infarction in Paroxysmal Nocturnal Hemoglobinuria. Report of 2 Cases and Updated Review of 7 Previously Published Patients
    • Audebert HJ, Planck J, Eisenburg M. Cerebral Ischemic Infarction in Paroxysmal Nocturnal Hemoglobinuria. Report of 2 Cases and Updated Review of 7 Previously Published Patients. J Neurol 2005;252:1379-1386.
    • (2005) J Neurol , vol.252 , pp. 1379-1386
    • Audebert, H.J.1    Planck, J.2    Eisenburg, M.3
  • 9
    • 15944398355 scopus 로고    scopus 로고
    • The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease
    • Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005;293:1653-1662.
    • (2005) JAMA , vol.293 , pp. 1653-1662
    • Rother, R.P.1    Bell, L.2    Hillmen, P.3    Gladwin, M.T.4
  • 10
    • 34147156839 scopus 로고    scopus 로고
    • Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders
    • De Stefano V, Fiorini A, Rossi E. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Throm Haemost 2007;5:708-714.
    • (2007) J Throm Haemost , vol.5 , pp. 708-714
    • De Stefano, V.1    Fiorini, A.2    Rossi, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.